Which advanced-stage NSCLC patients attain long-term survival?

被引：0
|
作者：
Wang, Tina J. [1 ]
Bogardus, Alicia [1 ]
Nelson, Rebecca [1 ]
Grannis, Frederic [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：589S / 590S
页数：2
相关论文
共 50 条
  • [41] Living Through Ovarian Cancer Treatment Acute and Long-Term Toxicities of Chemotherapy for Advanced-Stage Disease
    Gockley, Allison
    Wright, Alexi
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 1073 - +
  • [42] Patient reported physical function (PF) predicts long-term survival in early-stage NSCLC surgical patients
    Pompili, C.
    Omar, S.
    Hylias, H.
    Campisi, A.
    Velikova, G.
    Valuckiene, L.
    Brunelli, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S73 - S74
  • [43] The Modern Role of Radiation Therapy in Treating Advanced-Stage Retinoblastoma: Long-Term Outcomes and Racial Differences
    Orman, Amber
    Koru-Sengul, Tulay
    Miao, Feng
    Markoe, Arnold
    Panoff, Joseph E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (05): : 1037 - 1043
  • [44] Comparison of Long Term Outcomes in Robotic Versus Conventional Laparoscopy for Treatment of Advanced-Stage Endometriosis: Which Discipline Is Preferred?
    Sirota, Ido
    Nezhat, Farr
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 317A - 317A
  • [45] The value of progression-free survival to patients with advanced-stage cancer
    Lesley J. Fallowfield
    Anne Fleissig
    Nature Reviews Clinical Oncology, 2012, 9 : 41 - 47
  • [46] The value of progression-free survival to patients with advanced-stage cancer
    Fallowfield, Lesley J.
    Fleissig, Anne
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) : 41 - 47
  • [47] Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group
    Hirayama, Yasuo
    Ishitani, Kunihiko
    Ota, Shuithi
    Kurosawa, Mitsutoshi
    Kondo, Takeshi
    Takimoto, Rishu
    Mori, Akio
    Sakai, Hajime
    Torimoto, Yoshihiro
    Yamamoto, Satoshi
    Sato, Kazuya
    Iwasaki, Hiroshi
    Kohda, Kyuhei
    Ishida, Tadao
    Kakinoki, Yasuhiro
    Fukuhara, Takashi
    Kato, Junji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (03) : 281 - 289
  • [48] Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group
    Yasuo Hirayama
    Kunihiko Ishitani
    Shuithi Ota
    Mitsutoshi Kurosawa
    Takeshi Kondo
    Rishu Takimoto
    Akio Mori
    Hajime Sakai
    Yoshihiro Torimoto
    Satoshi Yamamoto
    Kazuya Sato
    Hiroshi Iwasaki
    Kyuhei Kohda
    Tadao Ishida
    Yasuhiro Kakinoki
    Takashi Fukuhara
    Junji Kato
    International Journal of Hematology, 2014, 100 : 281 - 289
  • [49] Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC
    Fiala, Ondrej
    Hosek, Petr
    Pesek, Milos
    Finek, Jindrich
    Racek, Jaroslav
    Stehlik, Pavel
    Sorejs, Ondrej
    Minarik, Marek
    Benesova, Lucie
    Celer, Adam
    Nemcova, Ivana
    Kucera, Radek
    Topolcan, Ondrej
    ANTICANCER RESEARCH, 2017, 37 (11) : 6469 - 6476
  • [50] Long-term Survival of Patients with Stage I mucinous Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (01) : 10 - 10
12345